The National Centre for Research and Development

search

Recommended

News

print
A A A

INNONEUROPHARM - new NCBR sectoral programme

20-01-2017

The National Centre for Research and Development (NCBR) has launched another sectoral programme. The NCBR has allocated PLN 190 million to support R&D in the pharmaceutical sector and increase research results commercialisation in ​​neuromedicine.

- PLN 190 million invested in the pharmaceutical sector and neuromedicine is an injection which gives a chance for a breakthrough solutions created by Polish companies. All the time we are waiting for effective drugs for Alzheimer and Parkinson diseases, diabetes and most cancers - says Deputy Prime Minister and Minister of Science and Higher Education Jarosław Gowin.

Implemented by the NCBR under the Operational Programme Smart Growth, INNONEUROPHARM aims to increase competitiveness and innovation of the Polish pharmaceutical sector - including neuromedicine - in the 2026 perspective. It was launched in response to a joint initiative of the Polish Association of Pharmaceutical Industry Employers and Polish Platform of Innovative Neuromedicine. Dedicated to entrepreneurs, the programme is the first of three new sectoral programmes launched by the NCBR this year.

- Sectoral programmes established by the NCBR in cooperation with the business sector are direct responses to the needs of individual economy sectors that rely on growth through innovation. Today another branch joins those already benefiting from NCBR support.  A branch whose development is of particular importance, both in the context of civilisation challenges as well as of global competition of pharmaceutical companies - says NCBR Director Prof. Maciej Chorowski.

The budget of the call for proposals announced by the NCBR on 20 January totals PLN 190 million. Enterprises or their consortia will be eligible to apply for grants worth up to PLN 40 million. The call will run from 22 February to 7 April 2017.

 

Implementation of the program will contribute to increasing R&D activities of enterprises and, consequently, to the growth of innovation within the Polish pharmaceutical sector. INNONEUROPHARM will see the implementation of innovative projects in areas such as:

 

  • Innovative medicinal products,
  • Innovative manufacturing technologies of medicinal products,
  • Innovative diagnostic methods and new biomarkers for diagnosis and practical applications in the field of predictive neuromedicine
  • Innovative methods of rehabilitation of neuromedicine patients
  • Development of tools to support research into medicinal products

 

More information about INNONEUROPHARM is available on the NCBR website

Announcements
15-09-2017
We kindly inform that succeeding 3 applications submitted under the call for bilateral activities supported under the Fund for Bilateral Relations were verified from 31 August to 12 September 2017. Based on the results of verification 3 applications were funded for the total amount of 10 250 EUR.
15-09-2017
We kindly inform you that the deadline for completion of a visit supported under the Fund for Bilateral Relations has been extended. A visit must be finalized until 17 November 2017.
06-09-2017
We kindly inform that succeeding 3 applications submitted under the call for bilateral activities supported under the Fund for Bilateral Relations were verified from 11 August to 30 August 2017. Based on the results of verification 3 applications were funded for the total amount of 8250 EUR.
News
24-08-2017
The National Centre of Research and Development (NCRD) is looking for candidates for experts in the Smart Growth Operational Programme 2014-2020 (SG OP). The deadline for submitting application is the 15th of September, 2017, at 16:30.
12-07-2017
The National Centre of Research and Development (NCRD) is looking for candidates for experts in the Smart Growth Operational Programme 2014-2020 (SG OP).
01-06-2017
The National Centre of Research and Development (NCRD) is looking for candidates for experts in the Smart Growth Operational Programme 2014-2020 (SG OP). The deadline for submitting application is the 3rd of July, 2017, at 16:30.
21-04-2017
Saule Technologies, EcoElectronics, XTPL, Photon, Transition Technologies, Solaris Bus, Genicore, PIAP and VIGO Systems are just some of the NCBR beneficiaries who will be present at the Hanover Messe 2017.
10-04-2017
The National Centre for Research and Development (NCBR) launches two Funds of Funds (FOF), totalling PLN 2 bn for investments. NCBR CVC and NCBR VC will shape the technology investment market in the coming years.
24-03-2017
The National Centre of Research and Development (NCRD) is looking for candidates for experts in the Smart Growth Operational Programme 2014-2020 (SG OP). The deadline for submitting application is the 24th of April, 2017, at 16:30.

The National Centre for Research and Development
47a Nowogrodzka Str.,  00-695 Warszawa  office: +48 22 39 07 401  fax: +48 22 20 13 408
REGON: 141032404  NIP: 701-007-37-77

realizacja: Ideo powered by CMS Edito